GREGG TERRANCE H 4
4 · DEXCOM INC · Filed Jul 18, 2018
Insider Transaction Report
Form 4
DEXCOM INCDXCM
GREGG TERRANCE H
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2018-07-16$99.23/sh−5,600$555,700→ 55,282 total(indirect: By Trust) - Sale
Common Stock
2018-07-16$99.87/sh−3,900$389,496→ 51,382 total(indirect: By Trust) - Sale
Common Stock
2018-07-16$100.73/sh−500$50,365→ 50,882 total(indirect: By Trust)
Holdings
- 11,461(indirect: By IRA)
Common Stock
- 441,674
Common Stock
Footnotes (4)
- [F1]On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $98.64 and $99.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
- [F4]This transaction was executed in multiple trades at prices ranging from $99.64 to $100.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.